 | | PRD_002086 | | Formula: | C24 H34 N4 O8 | | Definition date: | 2013-10-02 | | Last modified: | 2022-10-29 |
|
 | | PRD_002087 | | Formula: | C18 H25 N5 O6 | | Definition date: | 2013-10-02 | | Last modified: | 2013-10-02 |
|
 | | PRD_002099 | | Name: | Uridine 5'Diphospho N-acetyl muramoyl-L-Alanyl-D-Glutamyl-L-Lysine | | Formula: | C34 H55 N7 O24 P2 | | Definition date: | 2013-10-02 | | Last modified: | 2023-06-11 |
|
 | | PRD_001124 | | Name: | Cyclomarin A | | Formula: | C56 H84 N8 O11 | | Definition date: | 2013-09-18 | | Last modified: | 2013-09-18 |
|
 | | PRD_001063 | | Name: | Beta-Hairpin Peptidomimetic antibiotic TWL(DAB)(ORN)(DLY)RW(ORN)(DAB)AK(DPR)P | | Formula: | C81 H131 N25 O15 | | Definition date: | 2013-09-11 | | Last modified: | 2013-09-11 |
|
 | | PRD_001068 | | Name: | beta-Hairpin Peptidomimetic Antibiotic TWLKKRRWKKAK(DPR)P | | Formula: | C87 H148 N27 O15 | | Definition date: | 2013-09-11 | | Last modified: | 2013-09-11 |
|
 | | PRD_001160 | | Name: | D-phenylalanyl-N-[(3S)-6-carbamimidamido-1-chloro-2-oxohexan-3-yl]-L-phenylalaninamide | | Formula: | C25 H33 Cl N6 O3 | | Definition date: | 2013-09-05 | | Last modified: | 2017-09-14 |
|
 | | PRD_001145 | | Name: | BIVALIRUDIN | | Formula: | C78 H110 N18 O30 | | Definition date: | 2013-09-04 | | Last modified: | 2013-09-04 |
|
 | | PRD_001148 | | Name: | BIVALIRUDIN | | Formula: | C20 H31 N6 O4 | | Definition date: | 2013-09-04 | | Last modified: | 2013-09-04 |
|
 | | PRD_001137 | | Name: | (4S,6aR,7aS)-5-{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl}-N-[(4R)-3,4-dihydro-2H-chromen-4-yl]octahydro-1H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-4-carboxamide | | Formula: | C30 H43 N5 O4 | | Definition date: | 2013-08-28 | | Last modified: | 2017-09-14 |
|
 | | PRD_001141 | | Name: | (3S,8aR)-N-((R)-chroman-4-yl)-2-((S)-2-cyclohexyl-2-((S)-2-(methylamino)propanamido)acetyl)octahydropyrrolo[1,2-a]pyrazine-3-carboxamide | | Formula: | C29 H43 N5 O4 | | Definition date: | 2013-08-28 | | Last modified: | 2017-09-14 |
|
 | | PRD_000874 | | Name: | PawS Derived Peptide 4 (PDP-4) | | Formula: | C59 H82 N18 O15 S2 | | Definition date: | 2013-08-21 | | Last modified: | 2013-08-21 |
|
 | | PRD_000875 | | Name: | PawS Derived Peptide 7 (PDP-7) | | Formula: | C65 H106 N20 O20 S2 | | Definition date: | 2013-08-21 | | Last modified: | 2013-08-21 |
|
 | | PRD_000939 | | Name: | modified protein phyllopod peptide BI-117E1 | | Formula: | C70 H131 N23 O16 S | | Definition date: | 2013-08-14 | | Last modified: | 2013-08-14 |
|
 | | PRD_000942 | | Name: | modified protein phyllopod peptide BI-117C3 | | Formula: | C79 H137 N25 O16 S | | Definition date: | 2013-08-14 | | Last modified: | 2013-08-14 |
|
 | | PRD_000943 | | Name: | Protein phyllopod | | Formula: | C74 H138 N24 O16 S | | Definition date: | 2013-08-14 | | Last modified: | 2013-08-14 |
|
 | | PRD_001070 | | Name: | bacitracin A2 | | Formula: | C66 H106 N17 O16 S | | Definition date: | 2013-08-14 | | Last modified: | 2013-08-14 |
|
 | | PRD_001133 | | Name: | (2R,6S,13aR,14aR,16aS)-6-{[(cyclopentyloxy)carbonyl]amino}-14a-[(cyclopropylsulfonyl)carbamoyl]-5,16-dioxooctadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl 3,4-dihydroisoquinoline-2(1H)-carboxylate | | Formula: | C37 H51 N5 O9 S | | Definition date: | 2013-08-07 | | Last modified: | 2020-07-20 |
|
 | | PRD_001138 | | Name: | (3S,7R,8aR)-2-{(2S)-2-(4,4-difluorocyclohexyl)-2-[(N-methyl-L-alanyl)amino]acetyl}-N-[(4R)-3,4-dihydro-2H-chromen-4-yl]-7-ethoxyoctahydropyrrolo[1,2-a]pyrazine-3-carboxamide | | Formula: | C31 H45 F2 N5 O5 | | Definition date: | 2013-08-07 | | Last modified: | 2017-09-14 |
|
 | | PRD_001139 | | Name: | (3S,8aR)-2-{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl}-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]octahydropyrrolo[1,2-a]pyrazine-3-carboxamide | | Formula: | C30 H45 N5 O3 | | Definition date: | 2013-08-07 | | Last modified: | 2017-09-14 |
|
 | | PRD_002097 | | Name: | [[[(4S)-5-[[(2S)-1-[[(2S)-5-[[azaniumylidene(azanyl)methyl]amino]-1-oxidanylidene-pentan-2-yl]amino]-3-methyl-1-oxidanylidene-butan-2-yl]amino]-5-oxidanylidene-4-[[(2S)-1-oxidanyl-1-oxidanylidene-3-phenyl-propan-2-yl]carbamoylamino]pentyl]amino]-azanyl-methylidene]azanium | | Formula: | C27 H46 N10 O6 | | Description: | Acts as a reversible inhibitor of serine/cysteine proteases and some trypsin-like serine proteases. | | Definition date: | 2013-08-07 | | Last modified: | 2022-10-20 |
|
 | | PRD_002098 | | Formula: | C29 H43 N10 O9 | | Definition date: | 2013-08-07 | | Last modified: | 2023-11-03 |
|
 | | PRD_000894 | | Name: | MM-102 | | Formula: | C35 H50 F2 N7 O4 | | Definition date: | 2013-07-31 | | Last modified: | 2023-11-03 |
|
 | | PRD_000895 | | Name: | MM-101 | | Formula: | C35 H52 N7 O4 | | Definition date: | 2013-07-31 | | Last modified: | 2023-11-03 |
|
 | | PRD_001136 | | Name: | SUGAR (6-MER) | | Formula: | C57 H82 O26 | | Description: | Chromomycin A3 is an anthraquinone. It is a glycosidic antibiotic produced at the fermentation of a strain of Streptomyces griseus. It is also called toyomycin. | | Definition date: | 2013-07-26 | | Last modified: | 2020-04-04 |
|
